Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Still, the FDA has not taken any concrete steps to regulate CBD, claiming that it needs more real-world data to move forward. “We Hemp Roundtable, the hemp industry’s national advocacy organization. “The

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

FEBRUARY 2, 2022

Alternative tests, such as the LuciX platform from Dutch company Bloonics, are able to provide detailed information about the cannabinoids present in someone’s system, including synthetic cannabinoids. “We Campaigners are calling for the government to revise the current laws and bring them up to date with contemporary data.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

MMJ Recs

MARCH 16, 2024

Regional economic impact studies provide policymakers, businesses, and community stakeholders with valuable data to inform decision-making, allocate resources, and maximize the positive outcomes associated with the medical marijuana industry’s presence in their respective regions.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Veriheal

AUGUST 31, 2020

Data shows that Hispanic Americans are more interested in using cannabis and CBD for wellness than other groups and “is believed to be in part due to the connections between the Hispanic community and nature.” Essay: “Crowdsourcing User Experience Data for a Targeted Medical Cannabis Journey with Cannamunity” .

Research and Development 117

Research and Development Education Agriculture Patients 117

Peninsula Alternative Health

MARCH 1, 2018

ASA works with a grassroots base of more than 50,000 members using public education and direct advocacy to affect national change. The website provides state-specific information about medical cannabis laws, lawyers, representatives, a congressional scoreboard, and state arrest data. Click here for more.

Treatment 40

Treatment Education Advocacy Access 40

Peninsula Alternative Health

MARCH 1, 2018

ASA works with a grassroots base of more than 50,000 members using public education and direct advocacy to affect national change. The website provides state-specific information about medical cannabis laws, lawyers, representatives, a congressional scoreboard, and state arrest data. Click here for more.

Treatment 40

Treatment Education Advocacy Access 40

CannaTech

AUGUST 9, 2018

We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.

Strains 69

Strains Epilepsy Advocacy Medicine 69

Cannabis Law Report

MARCH 9, 2019

They are taking issue with the change by the EU in its submission for the term ‘cannabinoids’ states: “Extracts of Cannabis sativa L. and derived products containing cannabinoids are considered novel foods as a history of consumption has not been demonstrated. He lectures widely on EU consumer and trading standards law. Notable cases.

CBD 87

CBD Food Seed-To-Sale Extraction 87

Cannabis Law Report

JUNE 10, 2021

Studies of crash or driving data suggest that, although permissive marijuana policies are associated with higher prevalence of tetrahydrocannabinol (THC) presence among drivers [ 1 , 2 ], there is mixed evidence that these policies are associated with motor vehicle crashes [ 3 , 4 , 5 , 6 , 7 , 8 , 9 ]. never vs. at least once). (2)

Policy 59

Policy Safety Marijuana Data 59

Cannabis Law Report

JULY 8, 2021

Despite the fact that cannabis also isn’t approved for use by the Food & Drug Administration, advocacy organizations claim that smoking cannabis is a viable treatment for a number of behavioral and health issues, ranging from tension and worry to Frontotemporal disease and Parkinson’s disease (FDA). percent or 16.7 million).

Legalization 98

Legalization Advocacy Legislation Cannabis 98

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. The recreational use of cannabis is well known and attributed to its power as a psychotropic plant, specifically due to the cannabinoid tetrahydrocannabinol (THC). Data collection. This offers a more denotative approach to complement the data.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

JANUARY 19, 2022

Today on the show we welcome Nikki Lawley, a Traumatic Brain Injury Survivor, and founder of NIKKI and the Plant, an advocacy group for medical marijuana use, with a special focus on helping women who have suffered a TBI. Nikki’s story is deeply inspirational, and we are honored to have had her on the show. EG: Definitely.

Patients 83

Patients Compliance Compliance Cannabis 83

Freedom Leaf

JANUARY 22, 2019

Eric Steenstra, president of Vote Hemp , a national advocacy organization dedicated to a free market for industrial hemp, thinks hemp farming will be only one trending item in 2019. Lanier expects CBD to continue to be an ongoing wellness trend as existing CBD businesses begin to diversify toward becoming full-spectrum cannabinoid companies.

Retail 68

Retail Legalization Food Hemp 68

Meadow

JULY 13, 2018

I feel like the dust is starting to settle a little bit and you know from the testing angle of it you know kind of looking at the data analytics and the statistics of what we’re seeing you know I have more and more hope and optimism by the day, especially around the idea of cooperative cannabis. They don’t do that!

Supply Chain 40

Supply Chain Compliance Compliance Cannabis 40

Cannabis Law Report

JUNE 4, 2021

Healing Advocacy Fund. Sam is the Executive Director of the Healing Advocacy Fund, which is the nonprofit organization supporting the implementation of Measure 109 in Oregon. Graham contributes to Psilocybin Alpha as editor-at-large, providing data for patent trackers and writing about IP in the psychedelics space. Sam Chapman.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

NORML

AUGUST 26, 2019

We had lawmakers who were just proposing lists of diseases that they felt were deserving, and we tried very narrow approaches, proposing two diseases, cancer and Crohn’s disease specifically, and we were being met with questions like, “Where are the data on that?” ” We later lowered the minimum cannabinoid requirement.

Marijuana 213

Marijuana Legalization Programs Oil 213